General Hepatology

Agency reviewers signal little support for first potential nonalcoholic steatohepatitis drug

Risk 40% lower with use among those with preexisting liver disease, study found

Roux-en-Y bypass or sleeve gastrectomy resolved NASH without exacerbating liver fibrosis

Years ago, she had a liver transplant. Now she leads Hopkins' pediatric liver transplant program

More research from the National Kidney Foundation Spring Clinical Meeting

Atezolizumab-bevacizumab reduced the risk of recurrence by about 30%

Goal of 30% reduction in serum creatinine in the absence of full response or HRS reversal

Chatbot may be able to provide "empathetic and practical advice"

Disparity mostly affects women, but allocating more livers from smaller donors may help

Randomized trial from China suggests no advantage to eating within an 8-hour window

Hospitalizations for liver toxicity declined after FDA limited acetaminophen dose

Easier alternative to six-food elimination diet shown effective

Both moderate and vigorous exercise reduced the risk of diabetes compared with no exercise

No survival benefit with three-drug chemo regimen or clear PFS gain with anti-PD-L1/bevacizumab